| abstract |
The present disclosure relates to compounds that bind to target RNA molecules, such as TPP riboswitches, compositions comprising the compounds, and methods of making and using the same. In contrast to compounds that bind only to a single RNA binding site, the compound contains two structurally distinct fragments that allow binding to target RNAs at two distinct binding sites bind, resulting in higher affinity 5-binding ligands. |